Pharmacist News & Journals
 |
Articles: General Pharmacy |
|
Receive free subspecialty "5-minute updates" via email
|
U.S. Opioid Risk Management Initiatives
Pain: Clinical Updates (IASP’s clinical newsletter), 11/20/09
Free full text
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/20/09 Pharmacogenetic profiling in the treatment of heart disease
Translational Research, The Journal of Laboratory and Clinical Medicine, 11/20/09 Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US
Current Medical Research and Opinion, 11/20/09 A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
Neurology, 11/20/09 Phase 2 study of two sequential three-drug combinations containing bortezomib, cyclophosphamide and dexamethasone, followed by bortezomib, thalidomide and dexamethasone as frontline therapy for multiple myeloma
British Journal of Haematology, 11/20/09 Metformin associated with lower cancer mortality in type 2 diabetes (ZODIAC-16)
Diabetes Care, 11/20/09 Aspirin is associated with reduced cardiovascular and all-cause mortality in type 2 diabetes in a primary prevention setting: The Fremantle Diabetes Study
Diabetes Care, 11/20/09 A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09 Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
British Journal of Cancer, 11/20/09 Comparison of daily insulin dose and other antidiabetic medications usage for type 2 diabetes patients treated with an analog basal insulin
Current Medical Research and Opinion, 11/20/09 Multicenter, Phase I, Dose-Escalation Trial of Lenalidomide Plus Bortezomib for Relapsed and Relapsed/Refractory Multiple Myeloma
Journal of Clinical Oncology, 11/20/09 Therapeutic Drug Monitoring of Posaconazole: a Monocentric Study with 54 Adults
Antimicrobial Agents and Chemotherapy, 11/20/09 A quality-adjusted survival analysis (Q-TWiST) of rituximab plus CVP vs CVP alone in first-line treatment of advanced follicular non-Hodgkin's lymphoma
British Journal of Cancer, 11/20/09 Mutations in Ribosomal Protein L3 Are Associated with Oxazolidinone Resistance in Staphylococci of Clinical Origin
Antimicrobial Agents and Chemotherapy, 11/20/09 Effect of Ethanol on the Release of Morphine Sulfate From Oramorph SR Tablets
American Journal of Therapeutics, 11/20/09 Medication use is associated with fatigue in a sample of community-living individuals who have a spinal cord injury: a chart review
Spinal Cord, 11/20/09 Transcriptomic Profiling of the Saccharomyces cerevisiae Response to Quinine Reveals a Glucose Limitation Response Attributable to Drug-Induced Inhibition of Glucose Uptake
Antimicrobial Agents and Chemotherapy, 11/20/09 Sub-lethal doses of an anti-erbB2 antibody leads to death by apoptosis in cardiomyocytes sensitized by low pro-senescent doses of epirubicin: the protective role of dexrazoxane
Journal of Pharmacology and Experimental Therapeutics, 11/20/09 Polyamine Transport as a Target for Treatment of Pneumocystis Pneumonia
Antimicrobial Agents and Chemotherapy, 11/20/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Pharmacist News & Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
250 Available Pages
|
|
